BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1775727)

  • 1. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
    Castoldi AF; Fitzgerald B; Manzo L; Tonini M; Costa LG
    Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):371-4. PubMed ID: 1775727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of [3H]AF-DX 384 to rat ileal smooth muscle muscarinic receptors.
    Entzeroth M; Mayer N
    J Recept Res; 1991; 11(1-4):141-52. PubMed ID: 1886077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic characterization of muscarinic receptors of insect brains.
    Abdallah EA; Eldefrawi ME; Eldefrawi AT
    Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
    Munns M; Pennefather JN
    Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
    Aubert I; Cécyre D; Gauthier S; Quirion R
    Eur J Pharmacol; 1992 Jul; 217(2-3):173-84. PubMed ID: 1425938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AF-DX 384 binding in rabbit cingulate cortex: two site kinetics and section autoradiography.
    Dopke KL; Vrana KE; Vogt LJ; Vogt BA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):562-9. PubMed ID: 7616446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
    Miller JH; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):601-7. PubMed ID: 1941609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM; Lapchak PA; Quirion R
    Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
    J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
    Araujo DM; Lapchak PA; Regenold W; Quirion R
    Synapse; 1989; 4(2):106-14. PubMed ID: 2781463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.